Continuum Advisory’s Innovator US Equity Ultra Buffer ETF September USEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Sell
7,491
-3,128
-29% -$127K 0.03% 379
2026
Q1
$411K Sell
10,619
-522
-5% -$20.5K 0.04% 314
2025
Q4
$438K Sell
11,141
-581
-5% -$22.6K 0.04% 301
2025
Q3
$453K Sell
11,722
-97
-0.8% -$3.67K 0.05% 290
2025
Q2
$436K Sell
11,819
-69
-0.6% -$2.42K 0.05% 280
2025
Q1
$409K Sell
11,888
-272
-2% -$9.6K 0.05% 268
2024
Q4
$428K Sell
12,160
-1,218
-9% -$42.8K 0.05% 263
2024
Q3
$471K Buy
13,378
+741
+6% +$25.2K 0.06% 252
2024
Q2
$427K Sell
12,637
-19
-0.2% -$630 0.06% 249
2024
Q1
$419K Sell
12,656
-135
-1% -$4.34K 0.06% 253
2023
Q4
$401K Buy
+12,791
New +$384K 0.06% 318

Other funds holding USEP

Continuum Advisory's USEP Position: Q2 2026 in Review

Continuum Advisory reduced its Innovator US Equity Ultra Buffer ETF September (USEP) stake by 29% in Q2 2026, selling an estimated $127K and leaving 7,491 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #379.

Continuum Advisory first reported a position in USEP in Q4 2023 and has held it in 11 quarters since. The position peaked at $471K in Q3 2024. 79 funds tracked by Wall St. Rank hold USEP as of Q2 2026.

  • Continuum Advisory held 7,491 shares of Innovator US Equity Ultra Buffer ETF September worth $310K as of Q2 2026.
  • Continuum Advisory sold 3,128 Innovator US Equity Ultra Buffer ETF September shares in Q2 2026, an estimated $127K.
  • Innovator US Equity Ultra Buffer ETF September made up 0.03% of Continuum Advisory's portfolio in Q2 2026, its #379 holding.
  • Continuum Advisory first reported a position in Innovator US Equity Ultra Buffer ETF September in Q4 2023 and has held it in 11 quarters since.
  • Continuum Advisory's Innovator US Equity Ultra Buffer ETF September position peaked at $471K in Q3 2024.
  • 79 funds tracked by Wall St. Rank held Innovator US Equity Ultra Buffer ETF September as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.